|
Main
|
|
Note: This record shows only 22 elements of the WHO Trial Registration Data Set. To view changes that have been made to the source record, or for additional information about this trial, click on the URL below to go to the source record in the primary register. |
|
Register:
|
ClinicalTrials.gov |
|
Last refreshed on:
|
8 February 2021 |
|
Main ID: |
NCT02277041 |
|
Date of registration:
|
26/10/2014 |
|
Prospective Registration:
|
No |
|
Primary sponsor: |
|
|
Public title:
|
Carbetocin Versus Misoprostol in Cases With Placenta Previa After C.S.
PPH |
|
Scientific title:
|
Carbetocin Versus Misoprostol for Prevention of Postpartum Hemorrhage in Cases With Placenta Previa After C.S. |
|
Date of first enrolment:
|
October 2014 |
|
Target sample size:
|
200 |
|
Recruitment status: |
Recruiting |
|
URL:
|
https://clinicaltrials.gov/show/NCT02277041 |
|
Study type:
|
Interventional |
|
Study design:
|
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Prevention. Masking: Triple (Participant, Care Provider, Outcomes Assessor).
|
|
Phase:
|
Phase 4
|
|
|
Countries of recruitment
|
|
Egypt
| | | | | | | |
|
Contacts
|
|
Name:
|
Nesreen A Shehata, MD |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
|
|
|
Name:
|
Nesreen A Shehata, MD |
|
Address:
|
|
|
Telephone:
|
00201227866337 |
|
Email:
|
nesoomar@yahoo.com |
|
Affiliation:
|
|
|
|
Name:
|
Nesreen A Shehata |
|
Address:
|
|
|
Telephone:
|
|
|
Email:
|
|
|
Affiliation:
|
Beni-Suef University |
|
|
Key inclusion & exclusion criteria
|
Inclusion Criteria:
- Women with a singleton pregnancy undergoing cesarean section after 37 weeks of
gestation.
Exclusion Criteria:
- • Women undergoing caesarean section with general anesthesia will be excluded, because
carbetocin is licensed for use with regional anaesthesia only.
- women undergoing caesarean section at less than 37 weeks of gestation.
- Hypertension with pregnancy.
- Cardiac and coronary diseases with pregnancy
Age minimum:
25 Years
Age maximum:
40 Years
Gender:
Female
|
|
Health Condition(s) or Problem(s) studied
|
|
Postpartum Hemorrhage
|
|
Intervention(s)
|
|
Drug: Misoprostol
|
|
Drug: Carbetocin
|
|
Primary Outcome(s)
|
|
Uterine tone and size
[Time Frame: One hour after the cesarean section]
|
|
Secondary Outcome(s)
|
|
Blood loss
[Time Frame: One hour after cesarean section]
|
|
Secondary ID(s)
|
|
Beni-Suef 8
|
|
Source(s) of Monetary Support
|
|
Please refer to primary and secondary sponsors
|
|
Results
|
|
Results available:
|
|
|
Date Posted:
|
|
|
Date Completed:
|
|
|
URL:
|
|
|
|